Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-262024-12-26truefalse2023-12-29truetruetrue269Food to go retailer specialising in breakfast, lunch, coffee and catering from prime site location in Central London and transport hubstruefalse271false 06878814 2022-12-30 2023-12-28 06878814 c:ReportableOperatingSegment1 2023-12-29 2024-12-26 06878814 c:ReportableOperatingSegment1 2022-12-30 2023-12-28 06878814 d:Audited 2023-12-29 2024-12-26 06878814 c:CurrentFinancialInstruments 2024-12-26 06878814 c:CurrentFinancialInstruments 2023-12-28 06878814 c:DevelopmentCostsCapitalisedDevelopmentExpenditure c:OwnedIntangibleAssets 2023-12-29 2024-12-26 06878814 c:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-29 2024-12-26 06878814 c:DevelopmentCostsCapitalisedDevelopmentExpenditure c:ExternallyAcquiredIntangibleAssets 2023-12-29 2024-12-26 06878814 c:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-26 06878814 c:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-28 06878814 d:Director1 2023-12-29 2024-12-26 06878814 d:Director7 2023-12-29 2024-12-26 06878814 d:Director8 2023-12-29 2024-12-26 06878814 d:FRS102 2023-12-29 2024-12-26 06878814 d:FullAccounts 2023-12-29 2024-12-26 06878814 c:Non-currentFinancialInstruments 2024-12-26 06878814 c:Non-currentFinancialInstruments 2023-12-28 06878814 c:MoreThanFiveYears 2024-12-26 06878814 c:MoreThanFiveYears 2023-12-28 06878814 c:BetweenOneFiveYears 2024-12-26 06878814 c:BetweenOneFiveYears 2023-12-28 06878814 c:WithinOneYear 2024-12-26 06878814 c:WithinOneYear 2023-12-28 06878814 d:OrdinaryShareClass4 2023-12-29 2024-12-26 06878814 d:OrdinaryShareClass4 2024-12-26 06878814 d:OrdinaryShareClass4 2023-12-28 06878814 c:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-12-26 06878814 c:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2023-12-28 06878814 c:OwnedOrFreeholdAssets 2023-12-29 2024-12-26 06878814 c:PlantMachinery c:OwnedOrFreeholdAssets 2023-12-29 2024-12-26 06878814 c:PlantMachinery 2023-12-29 2024-12-26 06878814 c:PlantMachinery 2024-12-26 06878814 c:PlantMachinery 2023-12-28 06878814 d:PrivateLimitedCompanyLtd 2023-12-29 2024-12-26 06878814 d:RegisteredOffice 2023-12-29 2024-12-26 06878814 c:RetainedEarningsAccumulatedLosses 2023-12-29 2024-12-26 06878814 c:RetainedEarningsAccumulatedLosses 2024-12-26 06878814 c:RetainedEarningsAccumulatedLosses 2022-12-30 2023-12-28 06878814 c:RetainedEarningsAccumulatedLosses 2 2022-12-30 2023-12-28 06878814 c:RetainedEarningsAccumulatedLosses 2023-12-28 06878814 c:RetainedEarningsAccumulatedLosses 2022-12-30 06878814 c:Buildings c:ShortLeaseholdAssets 2023-12-29 2024-12-26 06878814 c:Buildings c:ShortLeaseholdAssets 2024-12-26 06878814 c:Buildings c:ShortLeaseholdAssets 2023-12-28 06878814 f:UnitedKingdom 2023-12-29 2024-12-26 06878814 f:UnitedKingdom 2022-12-30 2023-12-28 06878814 c:ShareCapital 2023-12-29 2024-12-26 06878814 c:ShareCapital 2024-12-26 06878814 c:ShareCapital 2022-12-30 2023-12-28 06878814 c:ShareCapital 2 2022-12-30 2023-12-28 06878814 c:ShareCapital 2023-12-28 06878814 c:ShareCapital 2022-12-30 06878814 c:SharePremium 2023-12-29 2024-12-26 06878814 c:SharePremium 2024-12-26 06878814 c:SharePremium 2022-12-30 2023-12-28 06878814 c:SharePremium 2 2022-12-30 2023-12-28 06878814 c:SharePremium 2023-12-28 06878814 c:SharePremium 2022-12-30 06878814 c:CopyrightsPatentsTrademarksServiceOperatingRights c:OwnedIntangibleAssets 2023-12-29 2024-12-26 06878814 c:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-29 2024-12-26 06878814 c:CopyrightsPatentsTrademarksServiceOperatingRights c:ExternallyAcquiredIntangibleAssets 2023-12-29 2024-12-26 06878814 c:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-26 06878814 c:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-28 06878814 2023-12-29 2024-12-26 06878814 3 2023-12-29 2024-12-26 06878814 c:ExternallyAcquiredIntangibleAssets 2023-12-29 2024-12-26 06878814 1 2023-12-29 2024-12-26 06878814 5 2023-12-29 2024-12-26 06878814 2024-12-26 06878814 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-26 06878814 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-28 06878814 c:Non-currentFinancialInstruments c:AfterOneYear 2024-12-26 06878814 c:Non-currentFinancialInstruments c:AfterOneYear 2023-12-28 06878814 c:Non-currentFinancialInstruments c:MoreThanFiveYears 2024-12-26 06878814 c:Non-currentFinancialInstruments c:MoreThanFiveYears 2023-12-28 06878814 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2024-12-26 06878814 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2023-12-28 06878814 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2024-12-26 06878814 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2023-12-28 06878814 2 2022-12-30 2023-12-28 06878814 3 2022-12-30 2023-12-28 06878814 2023-12-28 06878814 2022-12-30 06878814 g:PoundSterling 2023-12-29 2024-12-26 06878814 c:RetainedEarningsAccumulatedLosses c:PreviouslyStatedAmount 2023-12-28 06878814 c:PreviouslyStatedAmount 2023-12-28 06878814 c:PriorPeriodErrorIncreaseDecrease 2023-12-28 06878814 c:SharePremium c:PriorPeriodErrorIncreaseDecrease 2023-12-28 06878814 c:RetainedEarningsAccumulatedLosses c:PriorPeriodErrorIncreaseDecrease 2023-12-28 06878814 c:ShareCapital c:PriorPeriodErrorIncreaseDecrease 2023-12-28 xbrli:shares iso4217:GBP xbrli:pure
Company registration number: 06878814







ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
26 DECEMBER 2024


HEALTHY RETAIL LIMITED








































img2716.png                        

 


HEALTHY RETAIL LIMITED
 


 
COMPANY INFORMATION


 Directors
Mr S D Craig 
Mrs A L Errington 
Mr C J F Andrews 




 Registered number
06878814



 Registered office
100 Moorgate

London

EC2M 6AB




 Trading Address
100 Moorgate

London

EC2M 6AB






 Independent auditor
Menzies LLP
Chartered Accountants & Statutory Auditor

4th Floor

95 Gresham Street

London

EC2V 7AB





 


HEALTHY RETAIL LIMITED
 



CONTENTS



Page
Strategic report
1 - 3
Directors' report
4 - 6
Independent auditor's report
7 - 10
Income statement
11
Statement of financial position
12
Statement of changes in equity
13
Notes to the financial statements
14 - 31


 


HEALTHY RETAIL LIMITED
 


 
STRATEGIC REPORT
FOR THE PERIOD ENDED 26 DECEMBER 2024

Introduction
 
The Directors present their strategic review of Healthy Retail Limited (“the Company” or “Pure”) for the 52-week period ending 26 December 2024. 

Principal activity

The Company trades as Pure. The Company is a multi-channel business with activities as a food-to-go retailer; caterer for meetings and conferences; and food-to-go wholesaler. Pure’s retail sites specialise in breakfast, lunch and coffee from prime locations in central London and transport hubs. Pure’s delivered-in catering business provides food for meetings, events and conferences. And Pure’s wholesale business specialises in locations where customers are on-the-go or at work

Business review
 
2024 and 2025 have seen the transformation of Pure from a multi-site to a multi-channel business. Pure ends 2025 with retail, catering and wholesale business streams, all in growth and all with lots more opportunities in 2026. Not since the end of 2019 has Pure entered a new year with such strong momentum.
2024 was the first year of the transformation to a multichannel business, which included the formal launch of Pure ‘food for business’ services. After four years of Covid-related impact, the decision was taken in September 2023 to diversify the business. This meant finding new investors, closing unprofitable shops and launching new business streams. This allowed the business to go from several years of significant losses to Adjusted EBITDA breakeven in 2024. This strong performance has continued into 2025, which will be the best EBITDA performance since 2019. And although Pure ended 2024 with three less retail sites than at the end of 2023, this did not stop company sales growing 6% to £23,552,820.
The turnaround in 2024 was even more impressive as it was still impacted by tube and rail strikes, as well as significant inflation. But the remarkable efforts of the Pure team to grow sales, find efficiencies and push ahead with the diversification of the business meant that 2024 was a very successful year.
The most impressive growth came from Pure’s delivered-in catering business. This grew to over £5,000,000 in 2024. Pure’s market-leading menu, the strength of the brand and the unrivalled customer service in this business channel, remains a core strength.
By the end of 2024, the business had also taken its first steps into wholesale, producing longer-life products which can then be sold by other companies. This included the huge team effort to get a SALSA license for Pure’s Central Kitchen in Q4 2024. This business channel has flourished in 2025 with new branding and a new range of products.
The shops continue to be the backbone of the business. It is the part of the brand that is most well known. Nothing is more emblematic of this recognition than Pure’s on-going success in major transport hubs, including Waterloo Station and Gatwick Airport. Pure’s core mission to create moments of joy when people are on the move is most significant in these locations.

Page 1

 


HEALTHY RETAIL LIMITED
 



STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 26 DECEMBER 2024

Principal risks and uncertainties
 
For the first time in five years, the risks and uncertainties that the Company faces are starting to diminish. Whilst the trading environment remains challenging, there is far more stability and certainty and measures to mitigate risks are as follows:
Government policy & tax changes
Changes to Employers National Insurance contributions in April 2025 was a significant cost increase for Pure (and every other hospitality business). But the Company does not expect any further significant changes to tax policy over the next 12 months.
Inflation and interest rates
Rapid inflation and the subsequent increase in interest rates has reduced disposable income for consumers over the last few years. But inflation is now gradually coming down, along with interest rates. The Company anticipates this trend continuing with some prices, such as electricity, coming down in 2026.
Working From Home
The one very significant change in consumer behaviour since the impact of Covid-19 is where people work. This has not changed significantly over the last 12 months but there is a gradual movement back to the office, particularly for larger companies, and the Company expects to see more people returning to offices over the next 12 months.
Travel strikes
Tube and train strikes impacted Pure in 2024. Other than a tube strike in September 2025, this has also largely stopped in 2025. The Company is hopeful that the worst is now behind us.
Credit & liquidity
On 22/12/2023, all shares of Healthy Retail Limited (HRL) were purchased by Healthy Retail Group Limited (HRGL). As part of the new investment structure, £1.5m was loaned to HRL on 22/12/2023, £1.5m was provided on 05/12/2024 and £0.5m on 22/12/25.
Supply chain
The Company is proud to serve the highest quality food and drink. If there were a fall in the standard of the goods supplied, or availability of products by the Company's supply chain partners, then there would be disruption and/or loss to the business. The Company continues to carefully select partners in this area that share its values to meet the high expectations set.
People
The Company’s employees are its key asset. The Company continues to review pay from Team Member to General Manager level and rewards staff with remuneration that benchmarks strongly when compared with the wider industry. The Company consults regularly with its employees via regular team meetings. It also holds an annual employee feedback survey and shares a weekly newsletter.

Page 2

 


HEALTHY RETAIL LIMITED
 



STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 26 DECEMBER 2024

Financial key performance indicators
 
The Company income statement for the 52 weeks ending 26 December 2024 is set out on page 11.
Operating loss decreased for the period to £1,232,508 (2023: loss of £1,806,829). With the year-on-year sales increase of 6% (2023: 11%) and a stable GP margin of 38.5% (2023: 38.5%) the improved operating loss demonstrates the improving business performance.
Loss for the financial period decreased to £1,391,283 (2023: loss of £3,022,593). Cash at bank as of 26 December 2024 was £1,327,154 (2023: £2,207,064).
The financial loss includes £0.45m of one-off costs or costs related to closed shops; £0.75m of depreciation and amortisation; and £0.16m in interest payments. The Adjusted EBITDA, excluding these costs, was breakeven in 2024. This improvement in EBITDA has continued into 2025.
 


This report was approved by the board and signed on its behalf.


Mr S D Craig
Director

Date: 30 December 2025

Page 3

 


HEALTHY RETAIL LIMITED
 


 
DIRECTORS' REPORT
FOR THE PERIOD ENDED 26 DECEMBER 2024

The directors present their report and the financial statements for the period ended 26 December 2024.

The directors have prepared the financial statements to 26 December 2024 to fall in line with the company's management accounting function, which uses a four-four-five weekly reporting cycle.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results

The loss for the period, after taxation, amounted to £1,391,283 (2023 -loss £3,022,593).

The directors do not recommend the payment of a dividend (2023: £nil).

Directors

The directors who served during the period were:

Mr S D Craig 
Mrs A L Errington 
Mr C J F Andrews 

Future developments

Following Covid-19 related disruption in 2020, 2021 and 2022 and the ongoing strike action in 2022, 2023 and 2024 Pure has taken the decision to pivot the business strategy and focus on its growing B2B business. Whilst it is imperative to maintain a strong retail presence with profitable stores, the Company will focus on growing the B2B sales.

Page 4

 


HEALTHY RETAIL LIMITED
 


 
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 26 DECEMBER 2024

Financial instruments

The Company finances its operations through a mixture of operating profits and, where necessary to fund expansion of capital expenditure programmes, bank and shareholder borrowings. Management's objectives are to:
 
retain sufficient liquid funds to enable it to meet its obligations as they fall due whilst maximising returns on sufficient funds, and
match the repayment schedule of any external borrowings or overdrafts with the future cash flows expected to arise from the Company's trading activities
 
The Company's surplus funds are held primarily in short term variable rate deposit accounts, which allows the Company to release cash resources at short notice if required. Deposits are with a reputable bank and the Directors believe their choice of bank minimises any credit risk.
The Company's Coronavirus Business Interruption Loan is linked to the Bank of England base rate, the carrying value at the at the balance sheet date was £2,091,549 (2023: £2,300,000). All other borrowings carry fixed interest charges.
Credit risk
The Company provides credit terms to a small number of regular customers. Aged debts are reviewed regularly, and if required credit terms are withdrawn until outstanding amounts are paid. Given the value of exposure and the effective credit control procedures in place, management consider the overall credit risk exposure to be low. There were a small amount of bad debt write-offs and no provisions made in the current or prior year.

Engagement with employees

Pure consults with employees via regular team meetings. An annual employee feedback survey is also held and a weekly newsletter is shared with teams across the Company.

Disabled employees

The Company recognises its responsibilities towards disabled persons and gives full and fair consideration to applicants in positions suited to their own particular abilities where appropriate openings exist. Where employees become disabled in the course of their employment, every effort is made to provide them with continuing employment.

Qualifying third party indemnity provisions

The Company maintains Directors' and officers' liability insurance which provides appropriate cover for legal action brought
against its Directors.

Matters covered in the Strategic Report

Details of principal activities have been disclosed in the strategic report.

Disclosure of information to auditor

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Page 5

 


HEALTHY RETAIL LIMITED
 


 
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 26 DECEMBER 2024

Post balance sheet events

Post year end an additional loan of £0.5m has been provided to the Company on 22/12/2025 in order to support its working capital requirements. 

Following the year end – and in-line with the Company’s strategy - three stores were closed. One of these was loss-making and the net book value of the fixed assets in this store was nil as it was fully impaired in a previous year. The other two stores had a NBV of £44,631 at the year end.

This report was approved by the board and signed on its behalf.
 




Mr S D Craig
Director

Date: 30 December 2025

Page 6

 


HEALTHY RETAIL LIMITED
 

img5220.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF HEALTHY RETAIL LIMITED

Opinion


We have audited the financial statements of Healthy Retail Limited (the 'Company') for the period ended 26 December 2024, which comprise the Income Statement, the Statement of Financial Position, the Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 26 December 2024 and of its loss for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Material uncertainty related to going concern


We draw attention to going concern disclosure note 2.3. As stated within these notes, the Company has net liabilities and there is significant doubt over its ability to continue as going concern. Our opinion is not modified in respect of this matter.


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Our evaluation of the directors' assessment of the Company's ability to continue to adopt the going concern basis of accounting included discussion with management their plans for the
future and working capital requirements. We reviewed management's forecasts and resources in place to continue to trade
as a going concern.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Page 7

 


HEALTHY RETAIL LIMITED


img32f2.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF HEALTHY RETAIL LIMITED (CONTINUED)

Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial period for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 8

 


HEALTHY RETAIL LIMITED


img131d.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF HEALTHY RETAIL LIMITED (CONTINUED)

Auditor's responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
The company is subject to laws and regulations that directly affect the financial statements including financial reporting
legislation. We determined that the following laws and regulations were most significant including:

FRS 102
Companies Act 2006
Tax Legislation
Employment Legislation

We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial
statement items.
We understood how the Company is complying with those legal and regulatory frameworks by, making inquiries to
management, those responsible for legal and compliance procedures and the company secretary. We corroborated our
inquiries through our review of board minutes.
The engagement director assessed whether the engagement team collectively had the appropriate competence and
capabilities to identify or recognize non-compliance with laws and regulations. The assessment did not identify any issues in
this area.
We assessed the susceptibility of the Company's financial statements to material misstatement, including how fraud might
occur. We considered the opportunities and incentives that may exist within the organisation for fraud and identified the
greatest potential for fraud in the following areas:
 
Posting of unusual journals and complex transactions
Management bias in the calculation of impairment provisions
Incorrect capitalisation of fixed assets resulting in an overstatement of fixed assets
Overstatement of income due to fictitious sales

As a result of the above, audit procedures performed by the engagement team included:
 
Identifying and assessing the measures management has in place to prevent and detect fraud;
Understanding how those charged with governance considered and addressed the potential for override of
            controls or other inappropriate influence over the financial reporting process;
Challenging assumptions and judgments made by management in its significant accounting estimates.
Page 9

 


HEALTHY RETAIL LIMITED


img3168.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF HEALTHY RETAIL LIMITED (CONTINUED)

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.




Nimita Chan FCCA (Senior statutory auditor)
  
for and on behalf of
Menzies LLP
 
Chartered Accountants
Statutory Auditor
  
4th Floor
95 Gresham Street
London
EC2V 7AB

30 December 2025
Page 10

 


HEALTHY RETAIL LIMITED
 


 
INCOME STATEMENT
FOR THE PERIOD ENDED 26 DECEMBER 2024

2024
As restated 2023
Note
£
£

  

Turnover
 4 
23,552,820
22,227,838

Cost of sales
  
(14,474,477)
(13,664,811)

Gross profit
  
9,078,343
8,563,027

Administrative expenses
  
(10,310,851)
(10,769,856)

Exceptional operating income
 5 
-
400,000

Operating loss
 6 
(1,232,508)
(1,806,829)

Interest receivable and similar income
 8 
3,337
2,556

Interest payable and similar expenses
 9 
(162,112)
(1,218,320)

Loss before tax
  
(1,391,283)
(3,022,593)

Loss for the financial period
  
(1,391,283)
(3,022,593)

There are no items of other comprehensive income for 2024 or 2023 other than the loss for the periodAs a result, no separate Statement of comprehensive income has been presented.

The notes on pages 14 to 31 form part of these financial statements.

Page 11

 


HEALTHY RETAIL LIMITED
REGISTERED NUMBER:06878814



STATEMENT OF FINANCIAL POSITION
AS AT 26 DECEMBER 2024

26 December
As restated 28 December
2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 13 
222,125
201,215

Tangible assets
 14 
2,570,183
3,065,803

  
2,792,308
3,267,018

Current assets
  

Stocks
 15 
117,608
134,563

Debtors: amounts falling due after more than one year
 16 
94,800
149,400

Debtors: amounts falling due within one year
 16 
488,602
293,522

Cash at bank and in hand
 17 
1,327,154
2,207,064

  
2,028,164
2,784,549

Creditors: amounts falling due within one year
 18 
(2,970,564)
(3,845,673)

Net current liabilities
  
 
 
(942,400)
 
 
(1,061,124)

Total assets less current liabilities
  
1,849,908
2,205,894

Creditors: amounts falling due after more than one year
 19 
(5,071,971)
(4,033,725)

Provisions for liabilities
  

Other provisions
 21 
(87,196)
(87,196)

  
 
 
(87,196)
 
 
(87,196)

Net liabilities
  
(3,309,259)
(1,915,027)


Capital and reserves
  

Called up share capital 
 22 
1,591
1,591

Share premium account
 23 
4,762,754
4,765,703

Profit and loss account
 23 
(8,073,604)
(6,682,321)

  
(3,309,259)
(1,915,027)


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


Mr S D Craig
Director

Date: 30 December 2025

The notes on pages 14 to 31 form part of these financial statements.

Page 12

 


HEALTHY RETAIL LIMITED
 



STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 26 DECEMBER 2024


Called up share capital
Share premium account
Profit and loss account
Total equity

£
£
£
£


At 29 December 2022
1,591
4,765,703
(16,578,096)
(11,810,802)


Comprehensive income for the period

Loss for the period

-
-
(3,022,593)
(3,022,593)


Other comprehensive income for the period
-
-
-
-


Total comprehensive income for the period
-
-
(3,022,593)
(3,022,593)


Contributions by and distributions to owners

Capital contribution
-
-
12,918,368
12,918,368


Total transactions with owners
-
-
12,918,368
12,918,368



At 28 December 2023
1,591
4,765,703
(6,502,099)
(1,734,805)

Prior year adjustment - correction of error
-
-
(180,222)
(180,222)


At 29 December 2023 (as restated)
1,591
4,765,703
(6,682,321)
(1,915,027)


Comprehensive income for the period

Loss for the period

-
-
(1,391,283)
(1,391,283)


Other comprehensive income for the period
-
-
-
-


Total comprehensive income for the period
-
-
(1,391,283)
(1,391,283)


Contributions by and distributions to owners

Transaction costs
-
(2,949)
-
(2,949)


Total transactions with owners
-
(2,949)
-
(2,949)


At 26 December 2024
1,591
4,762,754
(8,073,604)
(3,309,259)


The notes on pages 14 to 31 form part of these financial statements.

Page 13

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

1.


General information

Healthy Retail Limited (6878814) is private company, limited by shares, and  incorporated in England and Wales.  The principal place of business and the registered office is 100 Moorgate, London, EC2M 6AB.
The principal activity of the company is disclosed in the Strategic Report on page 1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The principal accounting policy has been set out below. These policies have been applied consistently to all
years reviewed, unless otherwise stated.
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The financial statements cover the 52 week period ending 26 December 2024.
The preparation of the financial statements is in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies. These areas involving a higher degree of judgment or complexity, or areas where uncertainty or estimates are significant to the financial statements are disclosed in note 3.
The presentation currency is Pound Sterling.

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Healthy Retail Group Limited as at 26 December 2024 and these financial statements may be obtained from Companies House.

Page 14

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

2.Accounting policies (continued)

 
2.3

Going concern

The ability of the Group and Company to continue as a going concern depends on them being able to continue in operation and meet their liabilities as they fall due for a period of at least 12 months (the Assessment Period) from the date these financial statements are authorised for issue. 

Assessment and Financial modelling
The Directors have prepared budgets, trading estimates and cash flow forecasts, covering the Assessment Period, alongside longer-term forecasts, internal and external considerations and market context to identify events or conditions that may cast significant doubt upon the continuing use of the going concern basis of accounting. The Directors have also prepared a sensitivity analysis by changing the most critical assumptions to assess impact on forecasts.

The most significant assumptions made by the Directors in preparing the forecasts were the level of sales volume growth within each of the multi-channel strategies, working capital profiles of the business and levels of cost inflation. Each of these assumptions requires the Directors to exercise significant judgement. The Directors have considered reasonable downside performance scenarios to satisfy themselves that in each scenario the going concern assumption is not broken.

Strategic backdrop and current trading
During 2025, the Directors implemented a multi-channel strategy to promote growth, increase efficiency and improve predictability of trading. Execution of this strategy in 2025 has started to deliver tangible and significant improvements in financial performance compared to prior periods. The Directors also note improving predictability of sales generated from the wholesale and corporate catering business lines, compared to a single store line of business where there is less predictability of sales volumes.  As a result, based on data from trading under the new strategy the Directors are confident that this trend of improvement will continue into 2026 and beyond, alongside a belief that the major risks facing the business can be mitigated by planned actions.

Market backdrop  
UK inflation is falling giving more stability to the cost base and less pressure to increase prices, which in turn should stabilise customer purchasing.  Bank base rates are also falling and predicted to fall further, which should improve all customer lines of business and reduce pressures on our suppliers to increase costs.  Whilst we are cautious in our outlook for a general return of employees to offices, we are beginning to see encouraging signs of workers having more of an office presence than in the last five years which should improve or at least stabilise store sales volumes. As a result, whilst the Directors acknowledge the risks inherent in the quick service food industry and have planned accordingly, there are signs that the general macroeconomic environment is at least stabilising and possibly improving.

Supportive shareholders
Based on trading in 2025 following adoption of the multi-channel strategy, the Directors were able to raise £0.5m of new funding from shareholders in December 2025, which provides the Directors with confidence that the major shareholder supports the strategic actions being taken and the future of the business.  Whilst there is always risk associated with a refinancing event, given the progress of the business, the recent successful raise and the improvement in trading thus far, the Directors do not consider there to be a material uncertainty concerning availability of financing.

Conclusion
Whilst the Company enters 2026 with sufficient funding to meeting its obligations in a range of reasonable trading scenarios, the principal risks and uncertainties section of this report highlights a range of items where uncertainty and risk remains elevated, and this may create material uncertainty regarding the company’s ability to continue as a going concern in more severe downside scenarios.

Page 15

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods
The company sells a range of products including food, beverages and catering services net of VAT and trade discounts. Revenue from the sale of food and beverages are recognised at the point of sale and revenue from catering services are recognised on delivery of the products.

  
2.5

Intangible assets

Intangible assets are initially recognised at cost. Once recognised, they are measured at cost less any accumulated amortisation and any accumulated impairment losses.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed five years.
Development Expenditure have estimated useful life of 3 -10 years. Development Expenditure relates to costs incurred for design and project management of the implementation of menu boards, new software and websites.
Trademarks have estimated useful life of 3 - 10 years. Trademarks relates to costs incurred for design and project management of the Pure brand.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when that cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to profit or loss during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Short-term leasehold property
-
Straight line over the term of the lease
Plant and machinery
-
Straight line over 3 to 10 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 16

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

2.Accounting policies (continued)

 
2.7

Other operating income

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.

 
2.8

Revaluation of tangible fixed assets

Individual freehold and leasehold properties are carried at current year value at fair value at the date of the revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. Revaluations are undertaken with sufficient regularity to ensure the carrying amount does not differ materially from that which would be determined using fair value at the reporting date.
Fair values are determined from market based evidence normally undertaken by professionally qualified valuers.

Revaluation gains and losses are recognised in other comprehensive income unless losses exceed the previously recognised gains or reflect a clear consumption of economic benefits, in which case the excess losses are recognised in profit or loss.

 
2.9

Stocks

Inventories have been valued at the lower of cost and estimated selling price less costs to sell. 
At each reporting date, inventories are assessed for impairment. If inventory is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 17

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

2.Accounting policies (continued)

 
2.10

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial
assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans
to related parties and investments in ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other
accounts receivable and payable, are initially measured at present value of the future cash flows and
subsequently at amortised cost using the effective interest method. Debt instruments that are payable or
receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at
the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the
arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt
deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the
financial asset or liability is measured, initially at the present value of future cash flows discounted at a market
rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan
from a director in the case of a small company, or a public benefit entity concessionary loan.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting
period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is
recognised in the Income Statement.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between
an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original
effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any
impairment loss is the current effective interest rate determined under the contract.

 
2.11

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount.

 
2.12

Leases

The Company recognises temporary changes in operating lease payments that arise from COVID-19 related rent concessions on a systematic basis over the periods that the change in lease payments is intended to compensate.

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Property, plant and equipment acquired under finance leases or hire purchase contracts is capitalised and depreciated in the same manner as other tangible fixed assets. The related obligations, net of future finance charges, are included in creditors.

Page 18

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

2.Accounting policies (continued)

 
2.13

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.14

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

 
2.15

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and
Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Company can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 19

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below.
Provision for impairment of tangible and intangible assets
FRS 102 requires management to assess at each reporting date where there are events or changes in circumstances that indicate the carrying amount of tangible and intangible assets may not be recoverable. Management will carry out an impairment test if there are indicators of impairment. This is a complex area involving management judgement. Further details of intangible and tangible assets can be seen in note 13 and 14.


4.


Turnover

An analysis of turnover by class of business is as follows:


2024
2023
£
£

Food and beverage sales
23,552,820
22,227,838

23,552,820
22,227,838


Analysis of turnover by country of destination:

2024
2023
£
£

United Kingdom
23,552,820
22,227,838

23,552,820
22,227,838



5.


Other operating income

2024
2023
£
£

Insurance claims receivable
-
400,000

-
400,000


Page 20

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

6.


Operating loss

The operating loss is stated after charging:

2024
2023
£
£

Impairment of tangible fixed assets
-
82,021

Other operating lease rentals
3,464,571
3,420,826

Loss on disposal of fixed assets
-
219,755

Costs of store closures, restructuring and one off costs
365,334
219,984


7.


Auditor's remuneration

During the period, the Company obtained the following services from the Company's auditor:


2024
2023
£
£

Fees payable to the Company's auditor for the audit of the Company's financial statements
27,900
32,100


8.


Interest receivable

2024
2023
£
£


Other interest receivable
3,337
2,556

3,337
2,556


9.


Interest payable and similar expenses

2024
2023
£
£


Bank interest payable
162,112
183,389

Other loan interest payable
-
1,030,491

Other interest payable
-
4,440

162,112
1,218,320

Page 21

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

10.


Taxation



Factors affecting tax charge for the period

The tax assessed for the year is higher than (2023 -higher than) the standard rate of corporation tax in the UK of 25% (2023 -23.52%). The differences are explained below:

2024
2023
£
£


Loss on ordinary activities before tax
(1,391,283)
(3,022,593)


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 -23.52%)
(347,821)
(668,526)

Effects of:


Expenses not deductible for tax purposes
(11,606)
51,501

Capital allowances for period in excess of depreciation
88,929
78,356

Non-taxable income
-
(1,170)

Unrelieved tax losses carried forward
270,498
539,839

Total tax charge for the period
-
-


Factors that may affect future tax charges

The Company has trading losses carried forward of £16,289,665 (2023: £15,293,032) to set off against future profits of the same trade.

Page 22

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

11.


Employees

Staff costs, including directors' remuneration, were as follows:


2024
2023
£
£

Wages and salaries
6,872,937
6,745,030

Social security costs
447,352
423,152

Cost of defined contribution scheme
121,862
118,169

7,442,151
7,286,351


The average monthly number of employees by activity, including the directors, during the period was as follows:


        2024
        2023
            No.
            No.







Head office
25
30



Store
244
241

269
271


12.


Directors' remuneration

2024
2023
£
£

Directors' emoluments
185,000
190,500

Company contributions to defined contribution pension schemes
18,582
12,937

203,582
203,437


During the period retirement benefits were accruing to 1 directors (2023 -1) in respect of defined contribution pension schemes.

The highest paid director received remuneration of £185,000 (2023: £182,500).
The value of the Company's contributions paid to a defined contribution pension scheme in respect of the highest paid director amount to £18,582 (2023: £12,937).
During the period NIL directors received shares under the long-term incentive schemes (2023: £NIL)
There are no others deemed to be key management personnel other than the directors.

Page 23

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

13.


Intangible assets






Development expenditure
Trademarks
Total

£
£
£



Cost


At 29 December 2023
778,206
91,172
869,378


Additions
136,399
-
136,399


Disposals
(10,400)
-
(10,400)



At 26 December 2024

904,205
91,172
995,377



Amortisation


At 29 December 2023
633,536
34,627
668,163


Charge for the period on owned assets
110,755
4,734
115,489


On disposals
(10,400)
-
(10,400)



At 26 December 2024

733,891
39,361
773,252



Net book value



At 26 December 2024
170,314
51,811
222,125



At 28 December 2023
144,670
56,545
201,215



Page 24

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

14.


Tangible fixed assets







Short-term leasehold property
Plant and machinery
Total

£
£
£



Cost or valuation


At 29 December 2023
4,535,444
3,235,805
7,771,249


Additions
132,819
102,408
235,227


Disposals
(9,733)
-
(9,733)



At 26 December 2024

4,658,530
3,338,213
7,996,743



Depreciation


As restated at 29 December 2023
2,655,395
2,050,051
4,705,446


Charge for the period on owned assets
274,078
456,769
730,847


Disposals
(9,733)
-
(9,733)



At 26 December 2024

2,919,740
2,506,820
5,426,560



Net book value



At 26 December 2024
1,738,790
831,393
2,570,183



At 28 December 2023
1,880,049
1,185,754
3,065,803

The net carrying amount of assets held on finance leases is £2,881 (2023: £40,676).
 


15.


Stocks

2024
2023
£
£

Stocks
117,608
134,563

117,608
134,563


Page 25

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

16.


Debtors

2024
2023
£
£

Due after more than one year

Other debtors
94,800
149,400

94,800
149,400


2024
2023
£
£

Due within one year

Trade debtors
245,185
83,025

Other debtors
177,017
143,821

Prepayments and accrued income
66,400
66,676

488,602
293,522



17.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
1,327,154
2,207,064

1,327,154
2,207,064


Page 26

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

18.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
380,282
208,451

Trade creditors
1,480,280
1,837,296

Other taxation and social security
429,637
725,952

Obligations under finance lease and hire purchase contracts
2,881
40,676

Other creditors
196,988
211,958

Accruals and deferred income
480,496
821,340

2,970,564
3,845,673


The following liabilities were secured:

2024
2023
£
£



HP liabilities and finance leases
2,881
40,676

Bank loans
380,282
208,451

383,163
249,127

Details of security provided:

HP liabilities and finance lease obligations are secured upon the assets to which they relate.
The Company received a bank loan of £3,000,000 under the Coronavirus Business Interruption Loan Scheme (CBILS). The loan is repayable in July 2030. The loan is charged at a floating interest rate of 1.94% plus the base rate. Under the terms of the CBILS loan the interest is payable by the UK Government for the first 12 months of the loan. The loan is secured by way of an unlimited debenture.

Page 27

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

19.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
1,711,267
2,091,549

Shareholder loans
3,000,000
1,500,000

Other creditors
360,704
442,176

5,071,971
4,033,725


The following liabilities were secured:

2024
2023
£
£



Bank loans
1,711,267
2,091,549

1,711,267
2,091,549




Page 28

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

20.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
380,282
208,451


380,282
208,451

Amounts falling due 1-2 years

Bank loans
380,282
380,282


380,282
380,282

Amounts falling due 2-5 years

Bank loans
1,140,845
1,140,845

Shareholder loans
3,000,000
1,500,000


4,140,845
2,640,845

Amounts falling due after more than 5 years

Bank loans
190,140
570,422

190,140
570,422

5,091,549
3,800,000


Under the terms of the shareholder loan agreement, the loan will remain classified as debt unless the Company achieves certain performance criteria. If these criteria are met, all or part of the loan will convert into preference shares.
As at the reporting date, the loan remains outstanding and is presented as a financial liability.

 
21.
 

Provisions
 





Dilapidations
Total


£

£




At 29 December 2023
87,196
87,196

At 26 December 2024

87,196

87,196


Page 29

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

22.


Called up share capital

2024
2023
£
£
Allotted, called up and fully paid



159,059 (2023: 159,059) Ordinary shares of £0.01 each
1,591
1,591

Ordinary Shares: The shares (a) carry full voting rights, (b) are entitled to participate in dividends and (c) carry no right of redemption.



23.


Reserves

Share premium account
This reserve records the amount above the nominal value received for shares sold, less transaction costs. 
Profit and loss account
This reserve records retained earnings and accumulated Profit/Losses.


24.


Prior year adjustment

A prior year adjustment of £180,222 has been recorded to correct the depreciation expense, which was understated in previous periods.


25.


Pension commitments

The company operates a defined contribution pension scheme. The assets of the company are held separately from those of the company in an independently administered fund. 
The pension cost charge represents contributions payable by the company to the fund and amounted to £103,280 (
2023: £105,232).


26.


Commitments under operating leases

At 26 December 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
3,662,334
3,082,608

Later than 1 year and not later than 5 years
7,820,949
6,831,186

Later than 5 years
2,069,932
3,214,924

13,553,215
13,128,718



Page 30

 


HEALTHY RETAIL LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 26 DECEMBER 2024

27.


Related party transactions

During the period an additional shareholder loan of £1.5m was received from Sophie Management Limited. The loan is interest free and repayable on 31 December 2027.


28.


Post balance sheet events

Post year end an additional loan of £0.5m has been provided to the Company on 22/12/2025 in order to support its working capital requirements. 
Following the year end – and in-line with the Company’s strategy - three stores were closed. One of these was loss-making and the net book value of the fixed assets in this store was nil as it was fully impaired in a previous year. The other two stores had a NBV of £44,631 at the year end.


29.


Controlling party

The parent of the smallest and largest group for which group accounts are prepared is Healthy Retail Group Limited, a company incorporated in the United Kingdom with a registered office of 100 Moorgate, London, United Kingdom, EC2M 6AB. RBC Trustees (Jersey) Limited is the ultimate controlling party.

 
Page 31